Markets.com Logo

PPLPHARMA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    191.6553$
  • Previous Close
    190.3483$
  • 52 Week Change
    126.20$
  • Day Range
    1.31$
  • 52 Week High/Low
    181.5006$ - 307.7007$
  • Dividend Per Share
    0
  • Market cap
    254 688 M$
  • EPS
    -0.7774
  • Beta
    0.055
  • Volume
    --

About

PPLPHARMA.NSE represents the equity shares of Piramal Pharma Limited, traded on the National Stock Exchange of India (NSE). Piramal Pharma Limited is a pharmaceutical company involved in contract development and manufacturing operations (CDMO), complex hospital generics, and India consumer healthcare products. The stock's performance reflects investor sentiment regarding the company's growth prospects, profitability, and overall financial health, influenced by factors such as pharmaceutical industry trends, regulatory changes, and company-specific developments. Trading in PPLPHARMA.NSE allows investors to participate in the potential gains (or losses) associated with the company's business activities.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Revenue, profit margins, and overall financial health directly impact investor confidence.

Industry Trends: Pharmaceutical sector growth, regulatory changes, and competitor activities influence market sentiment.

Market Sentiment: Overall economic conditions, investor risk appetite, and global market trends affect stock valuations.

Drug Approvals: Successful drug development, clinical trial outcomes, and regulatory approvals significantly boost stock price.

Patent Expiry: Expiration of key drug patents can lead to generic competition and decreased profitability, affecting the stock.

Mergers & Acquisitions: Potential mergers, acquisitions, or collaborations can create excitement or uncertainty, altering stock value.

Raw Material Costs: Fluctuations in the price of raw materials used in drug manufacturing can impact profitability.

Government Policies: Healthcare reforms, drug pricing regulations, and trade policies can influence the pharmaceutical industry.

Investor Confidence: Positive news, analyst ratings, and institutional investments can increase demand and stock price.

Global Events: Pandemics, geopolitical tensions, and economic crises can create volatility in the stock market.

Currency Fluctuations: Exchange rate changes can impact revenue from international sales and raw material import costs.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--